|
|
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma |
| 3R01CA235162-04S1 |
|
NCI |
2022 |
|
|
Investigating Microenvironmental Interactions in Leptomeningeal Metastasis |
| 5R01CA245499-03 |
|
NCI |
2022 |
|
|
Development and Application of T1rho Dispersion Imaging of Aging Muscle |
| 1K25AG076864-01 |
|
NIA |
2022 |
|
|
The protein tyrosine kinase SYK drives innate immune responses against Alzheimers Disease |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Parenchymal border macrophages in AD and CAA |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Interplay between meningeal lymphatics, high-density lipoproteins and border macrophages in cerebral amyloid angiopathy |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Project 3 - Astrocytic glutamate dysregulation in AD and VCID |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
Project 2 - Astrocytic insulin signaling and AD |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
Targeting Endosomal dysfunction as a new source of biomarkers for Alzheimers disease |
| 1R01AG071868-01A1 |
|
NIA |
2022 |
